Philip K. Yachmetz, SVP, General Counsel at SAVIENT PHARMACEUTICALS INC (SVNT), sold 30,500 shares at $1.01 ($31K) on 2013-02-04, disclosed to the SEC on 2013-02-06.
Scheduled sale ($31k) by SVP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.01 | 27,297 | $28K | 89.4% |
| 2 | $1.02 | 3,203 | $3K | 10.6% |
| Total | $1.01 avg | 30,500 | $31K | 100% |
| Filing → |
| SVNT | SELL | 2012-02-23 | $7K | — | Filing → |
| SVNT | BUY | 2011-09-16 | $29K | — | Filing → |
| SVNT | SELL | 2011-02-15 | $32K | — | Filing → |